Educational program for physicians to reduce use of non-steroidal anti-inflammatory drugs among community-dwelling elderly persons: a randomized controlled trial

Medical Care
W A RayM R Griffin

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most frequently prescribed drugs for patients 65 years of age or older, primarily for musculoskeletal symptoms of osteoarthritis. Because NSAIDs frequently cause serious gastrointestinal (GI) and other complications among elderly patients, expert guidelines for osteoarthritis recommend acetaminophen-based regimens, which are safer and often as effective as NSAIDs. Evaluate a physician education program that communicated guidelines for management of osteoarthritis in elderly patients that emphasized avoidance of NSAIDs when possible. The program reviewed NSAID risks and benefits and recommended: re-evaluating continuous NSAID users, considering substitution of up to 4 g/d of acetaminophen for the NSAID, and trying topical agents and nonpharmacologic measures. Randomized controlled trial among community-dwelling Tennessee Medicaid enrollees. Study physicians had 5 or more patients who: were community-dwelling Medicaid enrollees 65 years of age or older; had used NSAIDs regularly for at least 180 days; had had no medical care encounters during this period suggesting an indication other than osteoarthritis; and had 1 year of baseline and follow-up data. The study thus incl...Continue Reading

References

Apr 1, 1992·Annals of Internal Medicine·D T FelsonJ J Anderson
Jul 1, 1991·Journal of Clinical Pharmacology·A Whelton, C W Hamilton
Jul 11, 1991·The New England Journal of Medicine·M H Liang, P Fortin
Apr 1, 1990·Controlled Clinical Trials·W D Dupont, W D Plummer
Sep 1, 1990·Journal of the American Geriatrics Society·E A ChrischillesG A Drube
Jan 1, 1990·Health Affairs·W A RayR I Shorr
Nov 28, 1990·JAMA : the Journal of the American Medical Association·G R Gay
Feb 1, 1990·Archives of Internal Medicine·M T Stillman, P A Schlesinger
Apr 1, 1989·American Journal of Epidemiology·W A Ray, M R Griffin
Mar 1, 1986·Lancet·K SomervilleM Langman
Nov 1, 1986·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D C BraterR D Toto
Sep 1, 1988·Annals of Internal Medicine·M R GriffinW Schaffner
Feb 1, 1987·Seminars in Arthritis and Rheumatism·D C Brater
Jan 1, 1985·Kidney International·D C BraterW B Campbell
Jan 24, 1986·JAMA : the Journal of the American Medical Association·C E EvansS A Hewson
Mar 22, 1985·JAMA : the Journal of the American Medical Association·W A RayC F Federspiel
Oct 7, 1983·JAMA : the Journal of the American Medical Association·W SchaffnerW O Miller
Jul 15, 1994·Annals of Internal Medicine·D W Puett, M R Griffin
Aug 1, 1996·Journal of General Internal Medicine·W E SmalleyW A Ray
Nov 20, 1998·The New England Journal of Medicine·J P Kassirer
Feb 3, 1999·Lancet·C J Hawkey
Jun 13, 2000·Pharmacy World & Science : PWS·S Braybrook, R Walker

❮ Previous
Next ❯

Citations

Oct 18, 2002·Journal of the American Geriatrics Society·Sarah MeredithWayne A Ray
Jan 15, 2004·Annals of the Rheumatic Diseases·K D Brandt
Mar 5, 2004·American Journal of Public Health·Allan Donner, Neil Klar
Sep 25, 2012·World Journal of Gastroenterology : WJG·Fermín MearinJavier Zapardiel
Oct 1, 2008·Medical Teacher·Sydney C LinekerMichel Zummer
Aug 27, 2005·British Journal of Clinical Pharmacology·Sirpa HartikainenRaimo Sulkava
Apr 17, 2004·Journal of the American Geriatrics Society·Karen S Feldt
Jun 16, 2010·Journal of Evaluation in Clinical Practice·Svetlana Vladislavovna DoubovaRicardo Pérez-Cuevas
May 4, 2002·Best Practice & Research. Clinical Rheumatology·J A DesmeulesPierre Dayer
Dec 16, 2004·The Annals of Pharmacotherapy·Sirpa A HartikainenRaimo O Sulkava
Apr 11, 2012·Nature Reviews. Neurology·Anne CorbettClive Ballard
Jul 26, 2002·Pharmacoepidemiology and Drug Safety·Robert M Califf
Mar 28, 2007·The Journal of Continuing Education in the Health Professions·Jing TianRobert S Gold
May 9, 2008·Digestive Diseases·Nimish VakilMichio Hongo
Oct 18, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Steven A MazzucaPatricia M Gʼsell
Mar 29, 2018·European Journal of Clinical Pharmacology·Fabiane Raquel MotterVera Maria Vieira Paniz
Dec 21, 2019·The Cochrane Database of Systematic Reviews·Tomas PantojaJaviera Leniz Martelli
Aug 27, 2019·Journal of Pharmacy Practice·Addison P RaganAnna Mirk
Jul 27, 2018·Oxidative Medicine and Cellular Longevity·Suresh K KalangiPallu Reddanna

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.